Related references
Note: Only part of the references are listed.Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer.
María José Escamez et al.
Oncotarget (2015)
Inverse association between cancer and neurodegenerative disease: review of the epidemiologic and biological evidence
Jane A. Driver
BIOGERONTOLOGY (2014)
Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease
Jing Dong et al.
NEUROBIOLOGY OF AGING (2014)
MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation
Jose C. Garcia-Borron et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
Melanocortin 1 receptor and risk of cutaneous melanoma: a meta-analysis and estimates of population burden
Patricia F. Williams et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Meta-analysis of the relationship between Parkinson disease and melanoma
Rui Liu et al.
NEUROLOGY (2011)
Pesticide exposure and risk of Parkinson's disease-a population-based case-control study evaluating the potential for recall bias
Kathrine Rugbjerg et al.
SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH (2011)
Parkinson's disease and cancer risk: a systematic review and meta-analysis
Archna Bajaj et al.
CANCER CAUSES & CONTROL (2010)
Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation
Daren Low et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2010)
Multiple Pigmentation Gene Polymorphisms Account for a Substantial Proportion of Risk of Cutaneous Malignant Melanoma
David L. Duffy et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Geographic and Ethnic Variation in Parkinson Disease: A Population-Based Study of US Medicare Beneficiaries
Allison Wright Willis et al.
NEUROEPIDEMIOLOGY (2010)
No Role for Melanoma Treatment in the Association between Melanoma and Amyotrophic Lateral Sclerosis or Parkinson's Disease
Peter D. Baade et al.
NEUROEPIDEMIOLOGY (2010)
Genetic Determinants of Hair Color and Parkinson's Disease Risk
Xiang Gao et al.
ANNALS OF NEUROLOGY (2009)
MC1R variants, melanoma and red hair color phenotype: A meta-analysis
Sara Raimondi et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Melanocortin-1 receptor signaling markedly induces the expression of the NR4A nuclear receptor subgroup in melanocytic cells
Aaron G. Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Neuroprotective actions of melanocortins: a therapeutic opportunity
Anna Catania
TRENDS IN NEUROSCIENCES (2008)
Treatment with levodopa and risk for malignant melanoma
Jorgen H. Olsen et al.
MOVEMENT DISORDERS (2007)
Comprehensive evaluation of allele frequency differences of MC1R variants across populations
Meg R. Gerstenblith et al.
HUMAN MUTATION (2007)
SNPStats:: a web tool for the analysis of association studies
Xavier Sole et al.
BIOINFORMATICS (2006)
Nurr1 in Parkinson's disease and related disorders
YP Chu et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2006)
Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify Penetrance of CDKN2A mutations in French melanoma-prone pedigrees
V Chaudru et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Genomic medicine: Alzheimer's disease and Parkinson's disease
RL Nussbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
Share Paper
